Emerging noninvasive biochemical measures to predict cardiovascular risk

Area of Science:

• Cardiology
• Biomarkers
• Preventive Medicine

Background:

• Accurate cardiovascular risk stratification requires novel predictors.
• Existing methods may not fully capture the complexity of atherosclerotic plaque progression.
• Easily measurable and modifiable risk factors are essential for population-level screening.

Purpose of the Study:

• To review emerging biomarkers linked to atherosclerosis pathogenesis.
• To identify markers associated with plaque rupture and thrombosis.
• To explore their potential in predicting cardiovascular events such as stroke and myocardial infarction.

Main Methods:

• Literature review of recent epidemiological studies.
• Analysis of biomarkers related to lipoprotein metabolism, inflammation, coagulation, and endothelial function.
• Identification of markers associated with subclinical and clinical cardiovascular disease.

Main Results:

• Several new biomarkers identified, including those for lipoprotein metabolism, vitamin B12, fibrinolysis, coagulation, inflammation, infection, endothelial dysfunction, angiotensin system, and oxidative stress.
• These markers are linked to atherosclerotic plaque progression and acute cardiovascular events.
• Non-invasive markers for processes like apoptosis are currently lacking.

Conclusions:

• Emerging biomarkers show promise for enhancing cardiovascular risk assessment.
• A comprehensive understanding of these factors can refine primary and secondary prevention efforts.
• Further epidemiological research is necessary to validate the clinical utility of these novel biomarkers.